Intangible Asset Strategy Drives Growth

Grew company from $50M to $350M in 5 years

The Situation

  • Generic manufacturer developed new combination drug
  • Based on the initial advice the company received, the drug could not be effectively protected

The Client

Management Team: $50M+ Pharmaceutical Company


  • EverEdge was brought in to develop an intangible asset strategy that enabled the company to create significant barriers to entry
  • The product was launched to great success and led to a dramatic increase in client growth


Grew company from $50M to $350M in 5 years

Sign Up To Our Newsletter